Harmony Biosciences Receives FDA Approval for Expanded Use of Wakix® (Pitolisant) for the Treatment of Cataplexy in Adult Patients with Narcolepsy
Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of Xywav™ Oral Solution in Adult Patients with Idiopathic Hypersomnia
Jazz Pharmaceuticals announces a new collaborative relationship with the American Heart Association to address heart disease in sleep disorders.
